Limb girdle muscular dystrophy due to other sarcoglycan dysfunction
ICD-10 G71.0349 is a billable code used to indicate a diagnosis of limb girdle muscular dystrophy due to other sarcoglycan dysfunction.
Limb girdle muscular dystrophy (LGMD) due to other sarcoglycan dysfunction is a genetic disorder characterized by progressive weakness and wasting of the proximal muscles, particularly those around the hips and shoulders. This condition is caused by mutations in genes responsible for the production of sarcoglycans, which are essential components of the muscle cell membrane. The dysfunction of these proteins leads to muscle fiber damage and degeneration. Patients typically present with muscle weakness, difficulty in walking, and may experience muscle cramps and pain. The onset of symptoms can vary, with some individuals showing signs in childhood while others may not present until adulthood. Diagnosis is often confirmed through genetic testing, muscle biopsy, and electromyography (EMG). Management focuses on physical therapy, occupational therapy, and supportive care to maintain mobility and function. Understanding the specific type of sarcoglycan involved is crucial for prognosis and potential treatment options.
Detailed neurological examination findings, genetic testing results, and muscle biopsy reports.
Patients presenting with progressive muscle weakness, difficulty in ambulation, and family history of muscular dystrophy.
Ensure that all relevant diagnostic tests are documented to support the diagnosis and coding.
Genetic test results, family history, and detailed patient history regarding muscle symptoms.
Patients referred for genetic counseling after a diagnosis of muscular dystrophy.
Documentation should clearly outline the specific genetic mutations identified.
Used when confirming the diagnosis of limb girdle muscular dystrophy.
Documentation of clinical suspicion and rationale for genetic testing.
Neurology and genetics specialists should ensure comprehensive documentation.
Specifying the type of sarcoglycan dysfunction is crucial for accurate diagnosis, prognosis, and potential treatment options. Different types may have varying clinical presentations and management strategies.
